PLXP实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (13 Apr 2023 @ 04:00):

Stats
今日成交量	50.38M
平均成交量	4.86M
市值	2.53M
EPS	$0 ( 2023-11-09 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.223
ATR14	$0.0270 (469.57%)

Insider Trading

Date	Person	Action	Amount	type
2022-03-15	Giordano Natasha	Buy	4 100	Common Stock
2022-03-15	O'connor Rita M	Buy	3 700	Common Stock
2022-03-15	O'connor Rita M	Buy	10 000	Common Stock
2022-02-22	Valentino Michael J	Buy	80 000	Stock Option (right to buy)
2022-02-22	O'connor Rita M	Buy	110 000	Stock Option (right to buy)

INSIDER POWER
0.00
Last 94 transactions
Buy: 5 718 001 \| Sell: 1 856 163

音量相关性

長: 0.18 (neutral)

短: -0.79 (moderate negative)

Signal:(38.252) Neutral

PLx Pharma Inc 相关性

10 最正相关
ONCS	0.955
WISA	0.952
INSG	0.947
IMRX	0.943
PRTK	0.943
INVE	0.943
TOI	0.942
VERV	0.938
TIL	0.937
TFFP	0.935

10 最负相关
AGFS	-0.912
CCRC	-0.91
LRFC	-0.907
MNKD	-0.903
IBEX	-0.901
STAY	-0.896
LWAC	-0.894
NWFL	-0.892
HZNP	-0.889
SLGN	-0.887

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

PLx Pharma Inc 相关性 - 货币/商品

0.64
( weak )

0.79
( moderate )

0.00
( neutral )

0.78
( moderate )

-0.13
( neutral )

-0.79
( moderate negative )

PLx Pharma Inc 财务报表

Annual	2021
营收:	$8.21M
毛利润:	$3.40M (41.46 %)
EPS:	$-1.714

FY	2021
营收:	$8.21M
毛利润:	$3.40M (41.46 %)
EPS:	$-1.714

FY	2020
营收:	$30 430.00
毛利润:	$30.43 (0.10 %)
EPS:	$-1.740

FY	2019
营收:	$565 464
毛利润:	$0.00 (0.00 %)
EPS:	$-2.30

Financial Reports:

No articles found.

PLx Pharma Inc

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.